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Mice Lacking H2-M Complexes,
Enigmatic Elements of the MHC Class II
Peptide-Loading Pathway
Toru Miyazaki,* Paula Wolf,² Sylvie Tourne,* used immunoselection to isolate a set of mutant lines
recognized normally by some anti±MHC class II mono-Caroline Waltzinger,* AndreÂ e Dierich,*
clonal antibodies (MAbs) but ignored by others (MellinsNicolas Barois,³ Hidde Ploegh,²
et al., 1990). A similar phenotype could be engineeredChristophe Benoist,* and Diane Mathis*
by transfecting class II genes into lymphoblastoid lines*Institut de GeÂ neÂ tique et de Biologie MoleÂ culaire
bearing large deletions within both copies of the MHCet Cellulaire
(Riberdy and Cresswell, 1992; Ceman et al., 1992). Al-CNRS
though the class II molecules expressed by the twoINSERM
types of mutant line were of normal sequence, they wereUniversiteÂ Louis Pasteur
unusually unstable, dissociating into individual a and b67404 Illkirch Cedex
chains in sodium dodecyl sulfate (SDS) at room temper-C. U. de Strasbourg
ature (Mellins et al., 1990; Riberdy and Cresswell, 1992),France
a property thought to signify improper peptide loading²Center for Cancer Research
(Sadegh-Nasseri and Germain, 1991; Germain and Hen-Massachusetts Institute of Technology
drix, 1991). Indeed, peptides eluted from these atypicalCambridge, Massachusetts 02139
class II molecules were strikingly enriched for a nested³Centre d'Immunologie de Marseille Luminy
set of fragments derived from Ii, residues 81±104, also13288 Marseille Cedex 9
known as the class II±associated invariant chain pep-France
tides (CLIPs) (Riberdy et al., 1992; Sette et al., 1992).
The mutant lines all had the same defect in antigen
presentation: they could not present whole proteins toSummary
T cell hybridomas, but could present the corresponding
peptides (Mellins et al., 1991; Riberdy and Cresswell,We have generated mice lacking H2-M complexes,
1992; Ceman et al., 1992), a defect highly reminiscent ofcritical facilitators of peptide loading onto major histo-
that exhibited by cells lacking Ii (reviewed by Cresswell,compatibility complex class IImolecules. Ab molecules
1994).in these mice matured into stable complexes and were
These observations suggested the following, moreefficiently expressed at the cell surface. Most carried
detailed scenario: Ii and MHC class II molecules associ-a single peptide derived from the class II-associated
ate in the ER; Ii is gradually processed to CLIP duringinvariant chain; the diverse array of peptides normally
the intracellular transport of the complex and residence
displayed by class II molecules was absent. Cells from
in endocytic compartments; CLIP is replaced by a di-
mutant mice presented both whole proteins and short
verse set of peptides, promoting a conformationalpeptides very poorly. Surprisingly, positive selection
change in the complex and heightened stability; finally,of CD41 T cells was quite efficient, yielding a large and
stable complexes composed of class II molecules and
broad repertoire. Peripheral T cells reacted strongly to
a heterogeneous set of peptides are released to the cell
splenocytes from syngeneic wild-type mice, no doubt
surface. The replacement of CLIP by other peptides and
reflecting the unique peptide complement carried by
subsequent events evidently require a molecule absent
class II molecules in mutant animals. from the mutant lymphoblastoid lines.
Identification of this molecule was not long in coming.
Introduction Analysis of chromosome deletion mutants revealed that
it was encoded by a locus in the class II region of the
The intracellular transport of major histocompatibility MHC, somewhere between HLA-DP and HLA-DQ (Mel-
complex (MHC) class II molecules has been neatly lins et al., 1991; Riberdy and Cresswell, 1992; Ceman
adapted to favor their loading with peptides derived et al., 1992). This interval included some recently discov-
from extracellular proteins (Cresswell, 1994; Wolf and ered loci with suggestive properties: a gene with some
Ploegh, 1995). Shortly after their synthesis, class II a homology to class II a genes and another similar to class
and b chains dimerize and associate with the invariant II b genes were cloned from a human cDNA library (HLA-
chain (Ii). Ii blocks most peptides from binding to class II DMa and HLA-DMb) (Kelly et al., 1991); an a-like and
molecules in the endoplasmic reticulum (ER) and directs two b-like genes were simultaneously isolated from a
their egress from the ER and targeting to endocytic mouse library (H2-Ma, H2-Mb1, and H2-Mb2) (Cho et
compartments. In this acidic environment, Ii is dissoci- al., 1991b). It was not known at the time whether the
ated from class II molecules, and peptides derived from products of the Ma and Mb genes serve a necessary
proteins traveling the endocytic pathway are loaded in function, nor even whether they were expressed. None-
its place. Class II±peptide complexes are then trans- theless, the M genes were transfected into the mutant
ported to the cell surface, where they can be recognized lymphoblastoid lines in an attempt to complement their
by CD41 T cells. deficiencies. The transfections proved highly effective;
During the past few years, some intriguing intricacies either the Ma or Mb gene was required for some lines
have been superimposed on this sketchy scenario, (Morris et al., 1994; Fling et al., 1994), and both genes
mainly reflecting a series of observations with mutant were required for others (Denzin et al., 1994). Thus, it
was concluded that the Ma±Mb complex is the criticalhuman lymphoblastoid cell lines. Pious and colleagues
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facilitator of peptide loading absent from the mutant
lines. This notion was supported by biochemical experi-
ments showing that Ma and Mb form a heterodimeric
complex and by a series of observations establishing
that the complexes are localized in internal subcellular
compartments, coincident with class II molecules, rather
than at the cell surface (Sanderson et al., 1994; Karlsson
et al., 1994; Denzin et al., 1994). Direct evidence that
Ma±Mb performs a catalytic function, facilitating the dis-
sociation of CLIP and the association of other peptides,
has recently come from studies with soluble complexes
(Sloan et al., 1995; Denzin and Cresswell, 1995; Sherman
et al., 1995).
Although our understanding of these enigmatic ele-
ments has evolved rapidly, important issues remain un-
resolved. We have an appreciation of how Ma±Mb com-
plexes operate in some mutant human lymphoblastoid
lines, but can this be extrapolated to the murine system,
or to an organismal setting? The human and murine
molecules exhibit sufficient sequence similarity to sug-
gest functional homology, but the absence of analogous
mutant lines has precluded direct evaluation of the func-
tion of mouse H2-M complexes. Nor, as a consequence,
has mouse CLIP been very well characterized. The few
existing results on species-mismatched systems have
been rather disconcerting. The properties of murine
class II molecules in human mutant lines varied with the
particular allele and line examined, but more often than Figure 1. H2-Ma Gene Inactivation
not they achieved SDS stability or efficiently presented
(a) Organization of the wild-type Ma gene. Starting from the regional
whole proteins (or did both) (Brooks et al., 1994; Steb- map of Cho et al. (1991a), it was determined by PCR amplification
bins et al., 1995). Clearly, a true murine system is re- with primers in each of exons 1, 2, 3, and 4 (the sequence of the
primers was based on the data of Cho et al. [1991b]). The locationquired to generalize the observations on human mutant
and boundaries of the exons were determined by sizing the PCRlines. We also need to extend the findings to other pro-
products and sequencing the exon±intron boundaries (data notcesses in which antigen presentation has been impli-
shown). Exon 1 encodes the signal sequence, exon 2 the first exter-cated, given that presentation by lymphoblastoid lines
nal domain of the mature protein, exon 3 the second domain, and
is known to be representative of that by some, but cer- exon 4 the transmembrane region and cytoplasmic tail (yet another
tainly not all, antigen-presenting cell (APC) types (Lanza- exon may encode a 39 untranslated region, as in the human gene
[Radley et al., 1994]). R, EcoRI; H, HindIII; X, XhoI; K, KpnI.vecchia, 1990). We are at present entirely ignorant of
(b) The fragment used for targeting, with a neomycin resistancethe role of Ma±Mb complexes in T cell education in
gene (open box) replacement. The NotI site (shown in parentheses)the thymus or during the unfolding of a real immune
is artificial, derived from the original l clone from which this pBSKresponse.
subclone was derived.
It seemed important, then, to generate a strain of mice (c) The modified locus resulting from homologous recombination.
lacking Ma±Mb complexes. We accomplished this by The probe used for Southern blots is indicated, as are the 6.4 and
5.0 kb EcoRI hybridizable fragments in wild-type and mutant DNA,mutating the H2-Ma locus via homologous recombina-
respectively.tion in embryonic stem (ES) cells. Here we present a
(d) Ma gene expression in total spleen RNA of wild-type (1/1) orcharacterization of these animals, concentrating on the
mutant (0/0) littermates was assessed by semi-quantitative PCR.structure of MHC class II complexes, antigen presenta-
The amounts of template cDNA for RT±PCR correspond to 5 3 105,
tion, and selection of the T cell repertoire. 5 3 104, 5 3 103, or 5 3 102 cells.
Mice carrying the mutation in the heterozygous stateResults
(Ma1/2) were inter-crossed to produce homozygous mu-
tants (Ma2/2).Generation of Ma2/2 Mice
Mice incapable of making the H2-M complex were pro- To demonstrate that the alteration abolished expres-
sion of Ma, we performed polymerase chain reactionduced by mutating the single Ma locus. A DNA fragment
containing the entire Ma protein-coding sequence was (PCR)analysis of splenocyte RNA from Ma2/2 mice using
primers spanning exons 3 and 4. We could not detectcloned (Figure 1A), and a targeting vector was con-
structed by replacing all of exon 1 and part of exon 2 any RNA transcribed from the altered locus (Figure 1D).
with the neomycin resistance gene (Figure 1B). It was
electroporated into the P1 ES cell line, derived from a Transport, Maturation, and Display of MHC
Class II Molecules129 mouse (H2b) haplotype. G418-resistant clones were
isolated and screened by Southern blotting (Figure 1C). Transport and maturation of class II molecules was as-
sessed by biosynthetic labeling experiments. Spleno-Positive clones were injected into C57Bl/6 (B6) blasto-
cysts, and chimeric offspring were mated to B6 females. cytes were pulse labeled with [35S]methionine for 30 min,
Mice with a Null Mutation in the H2-Ma Gene
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Figure 2. Normal Maturation and Transport
of Ab Molecules in Ma-Deficient Mice
(A) Proper Golgi transport. Splenocytes from
Ma2/2 mice (0/0) or wild-type littermates
(1/1) were pulse labeled with [35S]methionine
for 30 min, followed by a chase in cold methi-
onine as indicated, and Ab complexes were
then immunoprecipitated with M5-114. One
half of the samples were digested with endo
H prior to electrophoresis, as indicated. as
and bs indicate the position of the endo
H±sensitive (high mannose) forms of Aa and
Ab chains before digestion; as(d) is the same
after endo H digestion; ar and br are endo H
resistant.
(B) Assembly into SDS-stable complexes of
altered mobility. Ab complexes were immuno-
precipitated with Y-3P and resolved by SDS±
PAGE, with or without boiling the samples
prior to loading. Complexes that are stable in
SDS at room temperature are bracketed; the
positions of free a and b chains are indicated.
(C) Normal Ab surface expression levels.
Splenocytes were stained with anti-Ab MAbs,
with an anti-IgM counterstain, and analyzed
by cytofluorometry. Ab-specific staining on
gated IgM1 B cells is shown by the darker line,
superimposed with negative control staining
(faint line). Wild-type-level staining of mutant
splenocytes detected with the four MAbs on
the left was also observed with several other
MAbs (Y-248, Y-237, Y-266, and Y-212; data
not shown).
and the label was chased with cold methionine for vari- In the precipitates from Ma2/2 cells, a small molecular
mass species running just below the dye front wasous times. Lysates were prepared, immunoprecipitated
with a polyclonal rabbit anti±MHC class I serum to con- clearly visible after 1 hr of chase and increased in quan-
tity with longer chase times. It was observed only attrol for comparable levels of 35S incorporation, and then
reprecipitated with M5/114, a MAb that recognizes Ab very low levels in precipitates from cells expressing Ma.
Its identification will be discussed below.molecules regardless of their degree of maturation (Ger-
main and Hendrix, 1991). Intracellular transport of class Finally, we analyzed class II molecules displayed at
the cell surface by staining with a panel of anti±class IIII molecules is normally accompanied by the maturation
of N-linked carbohydrates, reflected as an increase in MAbs (Figure 2C). Two types of pattern were observed.
Most reagents, including M5/114, Y-3P, Y-222, andapparent molecular mass and by the acquisition of en-
donuclease H (endo H) resistance. As illustrated in Fig- 3F12, stained immunoglobulin M positive (IgM1) spleno-
cytes from Ma2/2 mice very effectively: labeling of mu-ure 2A, these modifications were already evident with
splenocytes from both Ma1/1 and Ma2/2 mice after only tant B cells with this class of MAb averaged 120% that of
wild-type cells; immunohistological analysis of various1 hr of chase. The degree and kinetics of maturation
were indistinguishable for the two types of cells. tissues, including the thymus, gave similar results (data
not shown). One of these MAbs (3F12) recognizes anTo evaluate the stability of class II molecules made
in the absence of H2-M complexes, we precipitated the epitope mainly on the class II a chain, while two others
(M5/114 and Y-222) recognize the b chain (Landais etsplenocyte lysates with the MAb Y-3P, which preferen-
tially recognizes mature forms of Ab (Germain and Hen- al., 1986). On the other hand, staining by two Ab-specific
reagents, 40B and BP107, was markedly reduced ondrix, 1991). Half of the precipitated material was incu-
bated in SDS at room temperature, and the other half splenocytes from Ma2/2 mice. The reduction was only
partial for 40B, but staining by BP107 dropped to back-was dissociated by boiling. Figure 2B shows that SDS-
stable Ab molecules of the molecular mass expected for ground levels.
compact dimers (z50 kDa) first appeared after 1 hr of
chase in cells expressing H2-M and steadily increased
Loading of Class II Moleculesin quantity with longer chase times, concomitant with a
Based on previous findings with lymphoblastoid linesdecrease in SDS-labile molecules. In cells devoid of
lacking HLA-DM, we hypothesized that the low molecu-H2-M, SDS-stable molecules appeared with similar ki-
lar mass species coprecipitating with Ab molecules innetics, but exhibited a reduced mobility. The dichotomy
the pulse±chase samples from Ma2/2 mice was CLIP. Toin mobility was quite striking, as none of the mutant
test this notion, we labeled splenocytes from Ii-negativecomplexes was found at the position where most of the
wild-type complexes migrated. animals and Ma-positive and Ma-negative littermates
Cell
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Figure 3. Large Amounts of CLIP Peptide
Complexed with Ab Molecules of Ma-Defi-
cient Mice
(A) Large increase of a discrete peptide asso-
ciated with Ab complexes in Ma2/2 mice.
Splenocytes from homozygous (0/0), hetero-
zygous (1/0), or wild-type (1/1) littermates
and from an Ii-deficient mouse (Ii0) were la-
beled with [35S]methionine for 5 hr; Ab com-
plexes were immunoprecipitated with Y-3P
and resolved by SDS±PAGE after boiling. The
position of the a and b chains is indicated,
as is that of the low molecular mass species
(CLIP) predominant in immunoprecipitates
from mutant mice.
(B) The dominant peptide of Ab complexes in
Ma2/2 mice can be reprecipitated with anti-
CLIP. Y-3P immunoprecipitates prepared as
in (A) were denatured and reprecipitated with
anti-CLIP or anti-Ab antisera. The reprecipi-
tated samples were resolved by SDS±PAGE
after boiling, next to an aliquot of the starting
Y-3P-precipitated material.
(C) The dominant peptide of Ab complexes
in Ma2/2 mice coelutes with synthetic CLIP
peptides on RP-HPLC. Splenocytes were la-
beled for 3 hr, followed by a 3 hr chase. Y-3P
immunoprecipitates were denatured in acid
and run on an RP-HPLC column, and the
eluted peptideswere detected by scintillation
counting of fractions. A mix of unlabeled CLIP
peptides was added to the samples and de-
tected by ultraviolet absorption (arrows at the
top of the panel).
(D) CLIP expression on the cell surface.
Splenocytes were stained with MAb 30-2,
which detects the CLIP peptide associated
with Ab molecules (Eastman et al., 1996).
CLIP-specific staining on gated IgM1 B cells
is shown on the histograms (dark line) super-
imposed with negative control staining (faint
line).
for 5 hr, prepared lysates, and precipitated them with The peak fraction from the Ma2/2 sample was subjected
to automated Edman degradation. It yielded spikes ofY-3P (Figure 3A). There was a clear gradation in the
amount of the low molecular mass band precipitated in radioactivity at cycles 6, 8, and 14, allowing unam-
biguous identification of the CLIP sequence 86,the Ma-positive and Ma-negative samples: low in Ma1/1,
intermediate in heterozygotes, and very high in Ma2/2. KPVSQMRMATPLLM . . . (data not shown). While the
identification of these 14 N-terminal residues is solid,No such band was observed in samples from Ii2/2 mice,
which is consistent with the low molecular mass species we cannot be certain of whether or not there are addi-
tional C-terminal residues. In a prior study, peptidesbeing CLIP.
Definitive identification was made by twomeans. First, eluted from splenic Ab molecules from wild-type animals
included CLIP 86±100, i.e., with the same N-terminusthe Y-3P precipitates were dissociated by boiling in an
SDS-containing solution and reprecipitated with anti- but one residue longer (Rudensky et al., 1991).
Finally, a MAb directed against a synthetic humansera specific for either the Ab chain or murine CLIP
(Figure 3B). Recovery of Ab was comparable for the CLIP permitted us tovisualize CLIP-loaded Ab molecules
at the cell surface (Figure 3D). IgM1 splenocytes fromMa1/1 and Ma2/2 samples. Large amounts of the low
molecular mass material were observed in the anti-CLIP wild-type mice were stained, but only slightly above
background levels; B cells from heterozygous mutantreprecipitate of the Ma2/2, but not the Ma1/1, sample.
Second, we acid-extracted peptides from the Y-3P pre- animals exhibited somewhat stronger staining; and cells
from homozygous mutants were stained to very highcipitates of wild-type and mutant cells and subjected
them to reverse-phase high pressure liquid chromatog- levels, at least ten times higher than wild-type cells.
raphy (RP-HPLC) (Figure 3C). A sharp major peak of
radioactivity was observed in the Ma2/2 sample, its elu- Antigen Presentation
tion nearly coinciding with that of synthetic CLIP stan- As mentioned above, cells lacking HLA-DM or Ii gener-
dards. This peak was considerably reduced in the Ma1/1 ally present whole proteins very poorly, but are quite
sample. (The labeled material eluting later in both sam- able to present the corresponding peptides. To see
ples was in the range of whole proteins or large polypep- whether the Ma mutation resulted in faulty antigen pre-
sentation, we compared the ability of splenocytes fromtides and probably represented Aa, Ab, or Ii molecules.)
Mice with a Null Mutation in the H2-Ma Gene
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in the three types of mice (data not shown). Typical
staining profiles are presented in Figure 5A. The CD4/
CD8 plots to the left of Figure 5A show that the
CD41CD82 population was reduced in Ma2/2 animals
to about half the number of cells found in normal lit-
termates. The reduction was not as extreme as that
found in age-matched Ii2/2 animals, which had about a
quarter the normal number. Deficient positive selection
of the CD41CD82 population in Ii2/2 mice has been de-
scribed previously and is known to involve phenotypic
changes as well: residual levels of CD8 on most cells
and slightly reduced expression of CD3 (Viville et al.,
1993; Bikoff et al., 1993; Tourne et al., 1995). For both
of these features, cells from Ma-negative mice exhibited
a phenotype intermediate between those of cells from
wild-type and Ii-negative animals (Figure 5A, left and
center panels). A more discriminating view of the matu-
ration of CD41CD82 cells came from correlating the
expression of CD3 and the capacity to bind peanut ag-
glutinin (PNA) (Figure 5A, right panels). This permits the
distinction of two subpopulations: the most mature cells
(gate K) are PNA-negative and express marginally higher
CD3 than the less mature cells (gate L), which stain with
PNA. In wild-type mice, the former predominated, while
in Ii-negative animals there was a greater fraction ofFigure 4. Antigen Presentation in Ma-Deficient Mice
the latter, apparently arrested at that stage; hence aSpleen cells from wild-type, Ma-deficient, or Ii-deficient (Ii0) mice
were used as APCs for T hybridoma stimulation, read out as interleu- markedly lower K to L ªmaturation ratioº is observed.
kin-2 production (vertical scales are [3H]thymidine incorporation by The cells in Ma-negative animals displayed an interme-
the CTLL indicator cells). Antigens were provided in the form of diate phenotype: fewer CD41CD82 cells, but a close to
whole proteins (HEL, OVA, or apamin [APA], at top) or corresponding
normal maturation ratio.peptides (middle and bottom). Splenic APCs were fixed with para-
The total numbers of T cells in the lymph nodes andformaldehyde in some assays (bottom).
spleen were also very comparable in the three types of
mice (data not shown). However, as illustrated in Figure
wild-type, Ma-negative, and Ii-negative mice to present 5B, the relative contributions of the different populations
hen±egg white lysozyme (HEL) and ovalbumin (OVA) varied. The ratio of CD41 to CD81 cells was low in Ma-
proteins and the corresponding peptides to T cell hy- negative mice, although still higher than in age-matched
bridomas. As shown in Figure 4 (top), neither Ma2/2 nor Ii-negative animals (Figure 5B, left panels). The reduced
Ii2/2 splenocytes were able to present the whole proteins. ratios were due to both a decrease in numbers of CD41
The latter offered peptides as efficiently as wild-type cells and an increase in numbers of CD81 cells. The
cells, but, surprisingly, Ma2/2 splenocytes exhibited a phenotype of the residual CD41 cells was somewhat
10- to 20-fold reduction (Figure 4, middle). Poor peptide different in the two types of mutant: they displayed nor-
presentation was observed with either fresh or fixed mal levels of CD44 in Ma2/2 mice, but many expressed
Ma2/2 splenocytes (compare middle and bottom panels high levels in Ii2/2 animals (Figure 5B, right panels).
in Figure 4), indicating that the observed defect was not To characterize the T cell repertoire selected by the
dependent on peptide internalization and processing. class II molecules in Ma2/2 mice, we stained thymocytes
Another aspect of processing was evaluated by mea- and lymph node cells with a panel of anti-Vb and anti-
suring the presentation of apamin. This 18 amino acid Va reagents. The data from lymph node cells are pre-
polypeptide requires reduction of a disulfide bridge, but sented in Table 1. Clearly, the Ma-negative animals ex-
not additional degradation, before it can be presented to pressed a very diverse repertoire, quite similar to that
the hybridoma T49.25 (ReÂ gnier-Vigouroux et al., 1988). of Ma-positive littermates. All variable regions were rep-
Neither Ma- nor Ii-deficient splenocytes could present resented in essentially normal proportions, with no over-
apamin to this hybridoma (Figure 4, right-most panel). representation by any particular Vb or Va. Some minor
differences were seen, such as higher numbers of Vb51
T Cell Differentiation and Va21 cells in the mutants, but further study will be
Having established that cells from Ma2/2 mice displayed required to elucidate their significance.
normal levels of MHC class II molecules predominantly
loaded with CLIP, we wondered how such molecules MLRs
would operate in the selection and maintenance of T The special peptide complement carried by class II mol-
cells. We therefore performed a cytofluorometric analy- ecules from Ma2/2 mice begged the question of how T
sis of thymic and peripheral T cell compartments in Ma- cells from these animals behave in the mixed lympho-
positive and Ma-negative littermates and, for compari- cyte reaction (MLR). Are they tolerant of the diverse set
son, in Ii-negative animals. of self-peptides presented by class II molecules from
normal mice?Total thymocyte numbers were essentially the same
Cell
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Figure 5. Partially Impaired Selection of CD41 Cells in Ma-Deficient Mice
(A) Thymocyte suspensions from the indicated mice were stained and analyzed by flow cytometry. The left panels display the CD4/CD8
profiles and the ab T cell receptor (TCRab) histograms of CD41 or CD81 single-positives (4 and 8), gated as shown. Ma heterozygotes were
indistinguishable from wild type in these experiments (data not shown). The values indicate the percentages of CD41CD82 cells in these thymi
(an average of five different determinations) and the ratio of CD4 to CD8 single positives. In the panels to the right, the thymocytes were
stained with reagents specific for CD3, CD4, and CD8 and with PNA±fluorescein isothiocyanate. The panels display the CD3±PNA profiles of
gated CD41CD82 cells. The two subpopulations of CD4 single positives that can be split on this basis (low PNA, highest CD3 versus PNA
positive, high CD3) are highlighted. The number of cells falling within these gates is indicated (of a total of 75,000 thymocytes analyzed) for
a representative experiment. The K to L maturation ratio of CD4 single positives is also shown.
(B) To the left, CD4/CD8 profiles of lymph node cells are shown. The percentages of CD41 cells (an average of four to six experiments) and
the average CD4 to CD8 ratio are shown. To the right, CD44 staining profiles of CD41CD82 cells are shown.
Figure 6A depicts a representative MLR experiment, was as stimulatory as an allogeneic Ak molecule, if not
more so.illustrating that lymph node T cells from homozygous
Ma-mutant mice were unusually good responders. Most Figure 6B shows that the impressive syngeneic MLR
is one way. Splenocytes from Ma2/2 mice were unablestriking was their strong reaction to syngeneic APCs
from B6 mice, quite in contrast with T cells from hetero- to stimulate lymph node T cells from B6 animals. As
expected, neither could spleen cells from Ma1/1 lit-zygous Ma mutants, Ii mutants, and wild-type animals,
which made essentially no response (Figure 6A, left). termates, confirming the view that segregating minor
histocompatibility loci were not making a major contri-This difference was not due to segregating minor histo-
compatibility loci because three out of three Ma-nega- bution. Splenocytes from Ma-negative mice could, how-
ever, stimulate allogeneic T cells (data not shown).tive mice exhibited the ªsuper-responderº phenotype,
while six of six paired Ma-positive littermates failed to
respond. In addition, responses of Ma2/2 cells to H2b Discussion
stimulators from 129 mice were equally strong (data
not shown). Since challenges were performed in the Presentation of Proteins and Peptides by
APCs from Ma2/2 Mice Is Defectivepresence of anti-CD8 MAbs, and because T cells from
Ma-mutant mice did not react to APCs from B6 mutant Splenocytes from Ma-mutant mice were unable to pres-
ent whole proteins to T cell hybridomas derived fromanimals lacking MHC class II molecules (Figure 6A, cen-
ter), the response emanated from CD41 T cells reacting wild-type animals, a property shared with HLA-DM-defi-
cient human lymphoblastoid lines (Mellins et al., 1991;to class II molecules. T cells from Ma2/2 mice also
showed an increased response to allostimulation by Riberdy and Cresswell, 1992; Ceman et al., 1992). This
defect almost certainly reflects an inability to strip MHCAPCs from B10.BR mice, although the increase vis-aÁ -
vis T cells from Ma1/1 mice was modest (Figure 6A, right). class II molecules of CLIP in the endocytic pathway and
replace them with peptides processed from internalizedThus, to T cells from Ma-negative mice, a syngeneic Ab
molecule loaded with the usual spectrum of peptides proteins. It is worth stressing that this represents the
Mice with a Null Mutation in the H2-Ma Gene
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Figure 6. High Reactivity of T Cells from Ma-
Deficient Mice against Self±Class II MHC of
Wild-Type Mice
(A) MLR responders were titrated lymph node
cells from various mice, as indicated, stimu-
lated with X-irradiated spleen cells from
MHC-matched B6 or Ab-deficient (Ab0) mice
or from MHC-mismatched B10.BR (H2k) mice.
In this representative experiment, 2 mg of
anti-CD8 MAb was added to the culture to
block responses directed against MHC class
I molecules.
(B) MLR was performed as above, with B6
lymph node responders and X-irradiated
spleen cells from various mice as stimulators.
examination of an entirely species-matched murine sys- present peptide antigens to T hybridomas efficiently
because, not requiring processing, peptides can betem: mouse H2-M complexes removing mouse CLIP
from mouse class II molecules. Class II molecules and loaded directly onto class II molecules at the cell sur-
face. Somewhat surprisingly, splenocytes from Ma-mu-their accessories, such as Ii and M, have coevolved,
so it would not be entirely surprising to obtain results tant mice were poor presenters of peptides. This was
true of either fresh or fixed cells, indicating that loadingdifferent from those derived from species-mismatched
systems. Indeed, most (though not all) assays of whole at the cell surface was probably affected, rather than
some process dependent on internalization and furtherprotein presentation by murine class II molecules in
HLA-DM-deficient human cell lines showed little reduc- processing. Thus, the poor presentation was probably
due to inefficient replacement of CLIP by antigenic pep-tion in efficiency (Riberdy et al., 1992; Brooks et al.,
1994; Stebbins et al., 1995). Although the Ab allele was tides. Given reports that the affinity and kinetics of CLIP
binding vary widely with class II alleles (Avva and Cress-not assayed in these studies, they did include analyses
of alleles with high or low affinity for CLIP. well, 1994; Sette et al., 1995; Liang et al., 1995; Malch-
erek et al., 1995), one might predict that the defect inHuman lymphoblastoid cells lacking HLA-DM (Mellins
et al., 1991; Riberdy and Cresswell, 1992; Ceman et al., peptide presentation will not be observed when Ma-
mutant mice expressing other alleles are examined and1992) and cells without Ii (Cresswell, 1994) are able to
Table 1. T Cell Repertoire Variable Region Usage
Vb2 Vb4 Vb5 Vb6 Vb7 Vb8 Vb10 Vb11 Vb12 Vb14 Va2
6.8 6.1 2.3 7.2 1.3 19.7 3.6 4.4 3.7 9.1 9.8
CD4 1/2 6.8 6.7 1.6 7.1 1.4 20.0 3.5 4.0 2.5 10.3 13.9
6.4 6.0 1.9 7.5 1.5 17.9 3.4 4.2 2.5 8.4 14.6
5.5 7.6 5.4 6.5 1.3 18.2 2.1 4.9 3.4 11.2 10.5
2/2 5.1 9.0 4.4 7.1 0.9 16.6 5.9 5.3 4.0 18.6 8.1
4.7 7.9 4.3 8.0 1.6 14.5 2.6 4.9 2.9 11.3 8.9
5.9 3.5 13.3 5.6 4.4 17.4 4.1 5.8 2.7 2.5 6.9
CD8 1/2 5.3 5.7 9.4 5.7 4.4 18.8 4.1 5.6 2.3 2.4 8.1
4.9 3.6 9.8 6.5 5.1 17.0 4.2 6.5 2.3 2.7 8.3
5.7 3.6 17.1 6.7 3.9 16.5 3.0 5.7 2.8 6.8 9.0
2/2 4.8 4.2 17.6 5.6 3.7 19.0 6.1 6.3 3.2 6.8 7.5
4.5 3.6 14.5 7.4 4.7 17.4 3.0 6.2 3.0 6.4 8.3
Heterogeneous T cell repertoire in Ma-deficient mice. Percentage of gated CD41 cells expressing each of the variable regions, compiled from
several different experiments. V region usage frequencies in the CD81 population were indistinguishable in mutant and wild-type littermates
(data not shown). Results from 1/2 mice were similar to those of 1/1 controls (data not shown).
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will be found once human cells expressing more HLA be able to stimulate peripheral T cells of normal H2b
mice.class II alleles have been analyzed.
Together, these data argue that a very high proportion
of class II molecules in mutant mice was loaded with
How Much CLIP? CLIP. Kropshofer et al. (1995) have recently presented
To evaluate the data on T cell selection in Ma2/2 mice, evidence for self-release of human CLIP from HLA-DR:
it is important to estimate the fraction of mature class the 81±89 region destabilized binding of the 90±103
II molecules loaded with CLIP versus other peptides. stretch, promoting self-removal that did not require
Several arguments lead us to conclude that the vast HLA-DM. These data fit well with prior observations that
majority, if not essentially all, of the Ab molecules in treatment of HLA-DR±peptide complexes with acidic pH
the mutant mice carried CLIP, with few or none of the provoked release of CLIP, but only the longer species
peptides normally found in class II molecules from wild- (Urban et al., 1994). Self-release probably explains why
type animals. First, gels like that in Figure 2B indicated only about 50% of the class II molecules in DM-deficient
that the mobility of the SDS-stable complexes from cell lines carry CLIP (Riberdy et al., 1992; Sette et al.,
Ma2/2 splenocytes did not overlap with that of the bulk 1992). One might have expected to see a similar phe-
of complexes from Ma1/1 cells. Upon dissociation at nomenon in Ma2/2 mice. This did not appear to happen,
high temperature, the SDS-stable dimers from mutant probably because the CLIP peptide bound to Ab in the
mice gave rise to a massive amount of CLIP, almost mutant started at position86 and thus lackedmost of the
invisible after similar treatment of dimers from wild-type sequence required for self-removal. The murine system
animals. We suggest that class II±CLIP complexes have may have forfeited this option owing to more extensive
a reduced mobility, as has been observed for certain cleavage of Ii, or we may find that different alleles carry
other class II±peptide complexes (Sadegh-Nasseri and longer CLIPs and are thereby more susceptible to self-
Germain, 1991) and that essentially all of the SDS-stable release.
complexes in cells from Ma2/2 animals carried CLIP,
with no significant amount of the diverse complement
of peptides normally found in SDS-stable complexes. Ma2/2 Mice Have a Diverse T Cell Repertoire
How does this major perturbation of the array of pep-Second, radiometric analysis of gels like that in Figure
3A led to estimates of between 55% and 75% CLIP tides carried by class II molecules affect selection of
the T cell repertoire? As discussed above, negative se-occupancy. However, this is almost certainly an under-
estimate: there was probably dissociation and loss of lection was markedly altered, permitting the emergence
of cells reactive with syngeneic Ab carrying the full pano-peptide in the course of immunoprecipitation; there was
probably also a significant loss of peptide in the CLIP ply of peptides.
The role of peptides in the positive selection of T cellssize range in preparation of thegels for autoradiography,
compared with little or no loss of intact class II chains. is still the subject of considerable debate (for review
and references, see Jameson et al. [1995]). Three possi-Third, the absence of detectable BP107 staining of B
cells from Ma2/2 mice was in stark contrast to the nor- bilities have been considered: that peptides play no role;
that they are required for the generation or maintenancemal, even elevated, level of staining with other anti±class
II reagents. Had a substantial fraction of Ab molecules of stable MHC molecules, but do not contribute directly
to the specificity of T cell recognition (only by not in-carried the usual peptides, some staining with BP107
should have been detected. terfering); or, third, that peptides are directly recognized
by T cells and are a major contributor to specificity.The fourth and perhaps most compelling factor, since
it relates to what T cells actually see, was the strong Recent evidence based on adding peptides to fetal thy-
mus organ cultures supported the third possibility, butone-way syngeneic MLR. Lymph node T cells from Ma-
negative mice reacted strongly to stimulation by spleno- this approach was subsequently challenged. In addition,
all of these studies focused on positive selection medi-cytes from B6 animals, even more strongly than they
did to cells from allogeneic B10.BR animals. In contrast, ated by MHC class I molecules, leaving us almost com-
pletely ignorant of the role of peptides in class II±drivensplenocytes from Ma-negative mice could not stimulate
lymph node T cells from B6 animals. The simplest inter- selection.
In spite of their preponderant loading with CLIP andpretation of such a response pattern is that the class II
molecules in Ma2/2 mice carry little other than CLIP, their lack of the usual peptides, class II molecules in
Ma2/2 mice were surprisingly effective at selecting Tgiven that negative selection is a very sensitive screen-
ing process. In the thymi of mutant animals, thymocytes cells. The numbers of CD41CD82 cells were only slightly
reduced, considering either the intermediate or fully ma-would see mostly (or perhaps only) class II±CLIP com-
plexes, and so the emerging repertoire would remain ture populations, and the selected cells displayed a very
diverse set of receptors, showing no evidence of grosslyunpurged of many self-specificities because the rele-
vant MHC±peptide complexes were not encountered. skewed Vb or Va usage. This observation might be inter-
preted to support a purely structural role for peptideSince they are also not displayed in the periphery, the
repertoire would remain untolerized. T cells with these in positive selection, CLIP being sufficient to stabilize
mature forms of class II molecules at the cell surface.self-specificities would, however, be strongly stimulated
by APCs from normal animals displaying a diverse com- Alternatively, selection might be promiscuous, and the
CLIP peptide might be able to select a wide range ofplement of class II±peptide complexes. On the other
hand, splenocytes from mutant mice would display pre- receptors. (Might CLIP be a major selecting peptide in
normal mice as well?) To resolve this issue, it will bedominantly class II±CLIP complexes and thus would not
Mice with a Null Mutation in the H2-Ma Gene
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RT±PCRnecessary to assay the functional capabilities of this
Ma expression in total splenocyte RNA was determined by reverserepertoire, as well as to establish exactly how much
transcription±PCR (RT±PCR) as described elsewhere (Miyazaki etclass II molecules displaying non-CLIP peptides contrib-
al., 1996) with titrated amounts of splenocyte cDNA template, with
ute to its selection. Recent reports have claimed that primers at positions 406±426 and 782±803. We blotted and probed
very low levels of class II molecules can select a normal 10% of each reaction with Ma cDNA.
repertoire (Naujokas et al., 1995; Shachar et al., 1995);
Serological Reagents and Flow Cytometryhowever, we have not been able to confirm this in very
For descriptions of anti-Ab MAbs, see Landais et al. (1986) andsimilar experiments (data not shown), nor is such a claim
Viville et al. (1993). For secondary immunoprecipitations, we usedconsistent with the often surprising sensitivityof positive
polyclonal reagents against the cytoplasmic tail of Ab and a peptide
selection to class II expression levels in existing T cell covering the murine CLIP sequence (N. B., unpublished data). CLIP
receptor transgenic systems (e.g., Berg et al., 1990). bound to surface Ab molecules was detected with MAb 30-2 (East-
This last point brings up the intriguing differences man et al., 1996); this reagent cannot be used for biochemical purifi-
cation of class II±murine CLIP complexes. Reagents and conditionsin the T cell compartments of Ma2/2 and Ii2/2 mice. A
for staining T cells have been described previously (Chan et al.,reduction in the thymic CD41CD82 population was seen
1993).in both types of mutants, but the defects seemed dis-
tinct. In Ii-negative animals, the decrease was more pro- Peptides and Antigens
nounced, and differentiation seemed to be severely af- Peptides used were as follows: mouse Ii 81±104 and shorter variants
fected at the CD41CD8lo to CD41CD82 transition, a 81±103, 83±104, and 83±103; HEL 74±88; chicken OVA 323±339.
All peptides were synthesized by standard chemistry and HPLCmaturation step considered to require continued en-
purified. HEL, OVA, and apamin were obtained from Sigma; wholegagement between the T cell and MHC molecules on
HEL was repurified by ultrafiltration (Centricon) before use with Ii-stromal cells (Chan et al., 1993). In Ma-negative animals,
independent hybridomas.
the decrease was less severe, and the transition to the
fully mature state seemed largely unimpaired. It is not Immunoprecipitations and SDS±PAGE Analysis
clear which of the differences between class II mole- Spleen cells were labeled with [35S]methionine as indicated in the
figure legends and lysed in NP-40. Lysates were precleared fourcules in the two mutants (surface density, conformation,
times, and aliquots (representing identical cell equivalents for eachor peptide complement) underlie(s) the different matura-
extract) were immunoprecipitatedwith specificor control antibodiestion patterns, but these observations imply distinct rec-
and protein A±agarose and eluted in reducing SDS sample buffer
ognition requirements for maturing CD41CD82 cells at (for 5 min at 958C versus 20 min at 208C to detect SDS-stable hetero-
various points during the selection process: the select- dimers). All samples were analyzed by 12.5% SDS±polyacrylamide
ing signal(s) might be qualitatively or quantitatively dif- gel electrophoresis (SDS±PAGE) under reducing conditions. For re-
precipitation, Y-3P immunoprecipitates were denatured in 1% SDSferent for the initial entry into the pathway versus gradu-
at 958C, diluted 20-fold, and reprecipitated with anti-CLIP or anti-ation to a fully mature compartment.
Ab antiserum. For endo H digestion, precipitates were denatured in
0.5% SDS, 1% b-mercaptoethanol for 5 min at 958C and incubated
Perspectives for 60min at 378C without or with recombinant endo Hf (NewEngland
Biolabs) at 50,000 U/ml.This view of mice devoid of H2-M molecules has pro-
vided novel information and will open avenues of experi-
Peptide Analysis of Ab Complexesmentation concerning several points: the role of H2-M
Y-3P precipitates from lysates of 3H-labeled spleen cells were ex-
in the maturation and function of MHC class II molecules tracted in 0.1% TFA at 208C, spiked with a mixture of synthetic
and the effects of a dominant peptide on the selection CLIP (see above) as internal standards, and applied to an RP-HPLC
and response capacity of the T cell repertoire. column (DeltaPak C18, 39 3 150 mm; Waters). Elution was as fol-
lows: 5% acetonitrile in 0.1% TFA for 5 min and then a 5%±95%
acetonitrile gradient for over 30 min at 1 milliliter per minute. CLIPExperimental Procedures
standards were detected by absorbance at 214 nm. Fractions (0.5
ml) were collected, and aliquots were counted by liquid scintillation.
Mice The major radioactive HPLC peak was subjected to automated Ed-
B6, 129/Sv, B10.Br, Balb/c (Jackson Laboratory), Ab-deficient (Cos- man degradation (performed by the Biopolymers Laboratory at
grove et al., 1991), and Ii-deficient mice (Viville et al., 1993) were the Massachusetts Institute of Technology), and fractions were
maintained in a conventional facility. counted.
Antigen Presentation AssaysDisruption of the H2-Ma Gene
T hybridomas and stimulation protocols were as described pre-An 18 kb genomic l clone (GF11) including the whole Ma protein-
viously (Viville et al., 1993). When necessary, spleen cells were fixedcoding sequence was isolated from a D3 ES cell library probed with
by incubation with 0.5% paraformaldehyde in PBS for 30 min andan Ma cDNA fragment cloned into the EcoRI site of pBluescript
quenched with 0.2 M glycine in PBS.(pDM1, position 34±650; numbering as per Cho et al. [1991b]). A
targeting vector was constructed from a 9.1 kb NotI±KpnI fragment
MLRssubcloned by replacing a 1.8 kb XhoI±HindIII fragment (including
Responders (total lymph node cells) were cultured with stimulatorsexon 1 and a portion of exon 2) by an XhoI±HindIII fragment of
(X-irradiated total spleen cells) at various ratios for 4 or 5 days inpMC1-neo-poly(A). NotI-linearized DNA was electroporated into ES
96-well plates in 250 ml of DMEM supplemented with 10% fetal calfcells (129/Sv P1 line), and clones were selected as described else-
serum and 50 mM b-mercaptoethanol. Proliferation was assessedwhere (Miyazaki et al., 1996). Three homologous recombinants were
by [3H]TdR incorporation in the last 16 hr of culture.detected in 117 G418-resistant colonies by Southern blotting (EcoRI
digested and probed with the 2.2 kb KpnI±EcoRI fragment shown
in Figure 1). ES clone KV7 was injected into blastocysts, and chime- Acknowledgments
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